Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:52 PM
Ignite Modification Date:
2025-12-24 @ 6:52 PM
NCT ID:
NCT00077857
Eligibility Criteria:
Inclusion Criteria:
* women \>=18 years of age;
* \>=1 target lesion;
* locally advanced or metastatic breast cancer;
* demonstrated resistance to anthracycline;
* \>=2 regimens of chemotherapy for advanced/metastatic disease.
Exclusion Criteria:
* previous treatment with Xeloda, continuous 5-fluorouracil infusion, or other oral fluoropyrimidines;
* previous treatment with paclitaxel or docetaxel for advanced/metastatic disease.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00077857
Study Brief:
Protocol Section:
NCT00077857